KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

CareDx (CDNA) EBIAT (2016 - 2026)

CareDx's EBIAT history spans 14 years, with the latest figure at $2.8 million for Q1 2026.

  • On a quarterly basis, EBIAT rose 127.13% to $2.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$8.2 million, a 113.2% decrease, with the full-year FY2025 number at -$21.4 million, down 140.64% from a year prior.
  • EBIAT hit $2.8 million in Q1 2026 for CareDx, up from -$4.1 million in the prior quarter.
  • Over the last five years, EBIAT for CDNA hit a ceiling of $87.7 million in Q4 2024 and a floor of -$118.1 million in Q4 2023.
  • Historically, EBIAT has averaged -$13.7 million across 5 years, with a median of -$16.9 million in 2022.
  • Biggest five-year swings in EBIAT: tumbled 2759.97% in 2022 and later skyrocketed 174.26% in 2024.
  • Tracing CDNA's EBIAT over 5 years: stood at -$18.3 million in 2022, then crashed by 544.32% to -$118.1 million in 2023, then skyrocketed by 174.26% to $87.7 million in 2024, then crashed by 104.68% to -$4.1 million in 2025, then soared by 168.38% to $2.8 million in 2026.
  • Business Quant data shows EBIAT for CDNA at $2.8 million in Q1 2026, -$4.1 million in Q4 2025, and $1.7 million in Q3 2025.